Product Images Dobutamine In Dextrose

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Dobutamine In Dextrose NDC 0409-2347 by Hospira, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structural formula dobutamine hydrochloride - dobutamine 01

structural formula dobutamine hydrochloride - dobutamine 01

This appears to be a chemical compound with a molecular formula of CqgHp3sNOzeHCI and a molecular weight of 337.85. However, without further context or information, it is not possible to provide a useful description of the compound.*

structural formula dextrose - dobutamine 02

structural formula dextrose - dobutamine 02

Hospira Logo - dobutamine 03

Hospira Logo - dobutamine 03

Hospira Logo - dobutamine 04

Hospira Logo - dobutamine 04

PRINCIPAL DISPLAY PANEL - 250 mL Bag - 2,000 mcg/mL - dobutamine 05

PRINCIPAL DISPLAY PANEL - 250 mL Bag - 2,000 mcg/mL - dobutamine 05

DOBUTamine in 5% Dextrose Injection, USP is a sterile, nonpyrogenic solution for intravenous use. Each 100 mL contains dobutamine hydrochloride equivalent to 200 mg of dobutamine along with dextrose, metabisulfite, and edetate disodium dihydrate as stabilizers. The solution has a pH of 2.5 to 5.5 and a mOsmol or molal concentration of 270. It should be stored at controlled room temperature and must not be used in 200 series connections. The usual dosage should be followed as instructed in the insert, and it contains sulfites. Any drug additives should not be added to this solution. If the solution is clear and the container is undamaged, it must only be used in usual doses.*

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap - 2,000 mcg/mL - dobutamine 06

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap - 2,000 mcg/mL - dobutamine 06

This is a pharmaceutical product containing Dabutamine Hydrochloride in 5% Dextrose Injection, USP. It has a strength of 500 mg/250 mL and is packaged in a single-dose container. It is important to check for minute leaks in the container after removing the overwrap, as the sterility may be impaired. The solution may exhibit a pink color, but this does not affect its potency. The container should be stored at room temperature and away from freezing.*

PRINCIPAL DISPLAY PANEL - 250 mL Bag - 1,000 mcg/mL - dobutamine 07

PRINCIPAL DISPLAY PANEL - 250 mL Bag - 1,000 mcg/mL - dobutamine 07

This is a description of a drug called DOBUTamine which is available as an injection in 5% Dextrose solution. It comes in a strength of 250 mg/250 mL (1000 mcg/mL) and is used for intravenous administration. Each 100 mL of the solution contains Dobutamine hydrochloride equivalent to 100 mg of Dobutamine along with 5g dextrose, 25 mg sodium metabisulphite, and 10 mg edetate disodium dihydrate as stabilizers. The pH of the solution is 3.0 (2.5 to 5.5) and it has an osmolarity of 263 mOsmol/L. The drug should not be used with sulfites and should not be mixed with any other drug additives. The drug is sterile, nonpyrogenic and should be used only if the solution is clear and the container is undamaged. Storage instructions are also mentioned.*

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap - 1,000 mcg/mL - dobutamine 08

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap - 1,000 mcg/mL - dobutamine 08

This is a description of a medication called Dobutamine in 5% Dextrose Injection, USP. It is contained in a 250mL single-dose container with a tear notch. Each 100mL of the solution contains 100mg of Dobutamine Hydrochloride along with dextrose hydrous (5g with sodium metabisulfite 25mg), and other stabilizers. The medication is meant for intravenous use and may include hydrochloric acid and/or sodium hydroxide for pH adjustment. The medicine is stored at 20 to 25°C and should be protected from freezing. The overwrap is a moisture and oxygen barrier, and the medicine should not be used if the overwrap is damaged. The solution may exhibit a pink color, but significant loss of potency has not occurred even if discolored. The container should be inspected for leaks before use, and the solution should be discarded if there are any leaks as safety may be compromised. The medication is distributed by Hospira Inc, Lake Forest, IL, USA.*

PRINCIPAL DISPLAY PANEL - 250 mL Bag - 4,000 mcg/mL - dobutamine 09

PRINCIPAL DISPLAY PANEL - 250 mL Bag - 4,000 mcg/mL - dobutamine 09

This is a medication called Dobutamine which is combined with 5% dextrose for injection. Each 100ml contains Dobutamine Hydrochloride equivalent to 400mg of Dobutamine, dextrose hydrous 5g, sodium metabisulfite 25mg, and edetate disodium dihydrate 10mg added as stabilizers. It may contain Hydrochloric acid and/or sodium hydroxide for pH adjustment, and it's intended for intravenous use. The solution must be clear, and the container must be undamaged. The medication is distributed by Hospira, Inc. in the USA. The dosage details are not available.*

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap - 4,000 mcg/mL - dobutamine 10

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap - 4,000 mcg/mL - dobutamine 10

Product Name: Unknown Active Ingredient: Dabutamine Hydrochloride Dosage Strength: 1,000 mg/250 mL Dosage Form: Injection Indication: The injection is for intravenous use and is infused to increase cardiac output in patients with heart failure Special Instructions: Do not add any drug additives to the solution. Discard the solution if there are any tears or holes in the overwrap as it may lead to contamination. The solution may display a pink color, but it is safe to use as long as there is no significant loss of potency. Check the container for any leaks before use. Storage: Store at 20°C to 25°C (68°F to 77°F). Protect from light. Warning: Contains sulfites.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.